News
NIH’s Steven Ferguson will be speaking at the Licensing Executives Society (LES) upcoming virtual seminar titled Industry, Universities, and Government – How to Work Together Through Contracts. This seminar will take place on June 25, 2024 from 10am-1pm EST. “The interface between institutions doing
Register to attend the National Cancer Institute Technology Transfer Center's first NIH technology webinar of the year on May 22nd, 2024 at 11AM ET. Attendees will learn about a potential, novel treatment for Retinitis Pigmentosa (RP). Over 100,000 people in the U.S. and 1.5 million people worldwide
A mouse cell line engineered to produce camelid nanobodies for use against infectious diseases or for basic applications is available for licensing. Nanobodies: have equivalent binding specificity to antigens as antibodies but are more heat- and detergent-stable. can target epitopes that are not
Inventors at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) have created a wearable, wireless device and protocol for continuously monitoring pregnancy health. The device can monitor placental oxygenation levels, multiple physiological signals and